XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Assumptions Used for Valuation of Fair Value of Stock Options
The Black-Scholes option-pricing model was used to estimate the fair value of stock options granted during the nine months ended September 30, 2022 and 2021 with the following weighted average assumptions:
 

 
  
Nine Months Ended September 30,
 
  
2022
 
2021
Risk-free interest rate
  
1.71% - 4.17%
 
0.4% - 1.1%
Expected term (in years)
   5.8 - 6.1   5.3 - 6.1
Expected volatility
   90%   90%
Expected dividend yield
   0%   0%
Summary of Stock Option Activity
The following table reflects summarized stock option activity:
 

 
  
Stock Options
 
  
Weighted Average
Exercise Price
 
  
Weighted Average
Remaining Contractual
Life (in years)
 
  
Aggregate Intrinsic
Value (in thousands)
 
Outstanding at December 31, 2021
     3,835,618      $ 2.51                    
Granted
     1,932,050      $ 5.00                    
Exercised
     (31,848    $ 0.86                    
Forfeited
     (79,872    $ 6.35                    
    
 
 
                            
Outstanding at September 30, 2022
     5,655,948      $ 3.31        8.3      $ 39,818  
    
 
 
    
 
 
    
 
 
    
 
 
 
Vested and exercisable at September 30, 2022
     2,084,736      $ 1.75        7.1      $ 17,772  
    
 
 
    
 
 
    
 
 
    
 
 
 
Summary of Share-Based Compensation Expense Related to Stock Options
The Company recorded stock-based compensation expense related to stock options in the following expense categories of its condensed statements of operations for the periods shown (in thousands):
 
 
  
Three Months Ended September 30,
 
  
Nine Months Ended September 30,
 
 
  
            2022            
 
 
            2021            
 
  
            2022            
 
 
            2021            
 
General and administrative
   $ 563      $ 254     $ 1,525     $ 412  
Research and development
     277        50       648        145  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation
   $ 840      $ 304     $ 2,173     $ 557